title: Effect of tetracalcium dimagnesium phytate on bone characteristics in ovariectomized rats.
abstract: The aim was to evaluate the influence of dietary Ca-Mg-phytate consumption on the bone characteristics of ovariectomized rats, an animal model for postmenopausal osteoporosis. Twenty ovariectomized female Wistar rats were randomly assigned to two groups fed, respectively, with a non-phytate diet (AIN-76A) or the same diet enriched with 1% phytate (as the calcium magnesium salt, phytin). After 12 weeks of feeding the rats were sacrificed, and both femoral bones and L4 vertebra were removed from each rat. Bone mass, length, width, volume, and mineral density were measured, and the phosphorus, calcium, magnesium, and zinc contents of bones were determined. Deoxypyridinoline (a bone resorption marker) was measured in urine, and osteocalcin (a bone formation marker) was measured in serum. The calcium and phosphorus contents and bone mineral density were significantly higher in both femoral bones and L4 vertebra for phytate-treated rats in comparison to rats in the non-phytate group. Deoxypyridinoline was significantly increased in rats in the non-phytate treatment group. Ca-Mg-phytate consumption reduces bone mineral density loss due to estrogen deficiency. Thus, phytate exhibits effects similar to those of bisphosphonates on bone resorption and may be of use in the primary prevention of osteoporosis if larger studies in humans confirm these findings.
authors.affiliation: Laboratory of Renal Lithiasis Research, University Institute of Health Sciences Research, University of Balearic Islands, Madrid, Spain. fgrases@uib.es
authors.forename: Félix
authors.initials: F
authors.lastname: Grases
authors.forename: Pilar
authors.initials: P
authors.lastname: Sanchis
authors.forename: Rafael M
authors.initials: RM
authors.lastname: Prieto
authors.forename: Joan
authors.initials: J
authors.lastname: Perelló
authors.forename: Ángel A
authors.initials: ÁA
authors.lastname: López-González
mesh_terms: D000596:Amino Acids / Q000652:urine; D000818:Animals; D015415:Biomarkers / Q000097:blood / Q000652:urine; D015519:Bone Density; D001862:Bone Resorption; D001842:Bone and Bones / Q000737:chemistry* / Q000473:pathology*; D002118:Calcium / Q000032:analysis; D002136:Calcium, Dietary; D004032:Diet; D004195:Disease Models, Animal; D005260:Female; D005269:Femur / Q000737:chemistry / Q000473:pathology; D006801:Humans; D008159:Lumbar Vertebrae / Q000737:chemistry / Q000473:pathology; D008274:Magnesium / Q000008:administration & dosage / Q000032:analysis; D015675:Osteocalcin / Q000097:blood; D010012:Osteogenesis; D015663:Osteoporosis, Postmenopausal / Q000097:blood / Q000473:pathology / Q000517:prevention & control* / Q000652:urine; D010758:Phosphorus / Q000032:analysis; D010833:Phytic Acid / Q000627:therapeutic use*; D011897:Random Allocation; D051381:Rats; D017208:Rats, Wistar
chemical_list: D000596:Amino Acids; D015415:Biomarkers; D002136:Calcium, Dietary; D015675:Osteocalcin; D010758:Phosphorus; D010833:Phytic Acid; C036020:deoxypyridinoline; D008274:Magnesium; D002118:Calcium